Shah Nikita

Shah Nikita is listed in filings as Executive Vice President at Amneal Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 5, 2026, including sale activity. Recent filings connect the profile to Amneal Pharmaceuticals, Inc. (AMRX). The current snapshot covers public activity from Aug 16, 2024 to Mar 5, 2026. Reported amounts are shown as $239.1K to $305.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.